Comparison of Bleeding Risk Between Colistin–Tigecycline and Colistin–Carbapenem Treatment Regimens: A Retrospective Cohort Study

BACKGROUND: Antibiotic combination is commonly used to treat multidrug-resistant pathogens. Reports have indicated that tigecycline use is associated with hypofibrinogenemia. However, whether the bleeding risk of tigecycline is higher than that of other antibiotics remains unknown. The aim of this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yu-Ting, Yu, Chia-I, Chen, Pao-Yu, Wang, Chi-Chuan, Wu, Chien-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629913/
https://www.ncbi.nlm.nih.gov/pubmed/34858035
http://dx.doi.org/10.2147/IDR.S339188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629913/
https://www.ncbi.nlm.nih.gov/pubmed/34858035
http://dx.doi.org/10.2147/IDR.S339188

Ejemplares similares